Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the securities of Adamas Pharmaceuticals, Inc. between August 8, 2017, and September 30, 2019, inclusive.
December 12, 2019
· 3 min read